Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: The OFELY study

Osteoarthritis and Cartilage

Volumn 23, Issue 10, 2015, Pages 1736-1742

  Rousseau, J C ^a   Sornay Rendu, E ^a   Bertholon, C ^a   Garnero, P ^a,b   Chapurlat, R ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Cisbio Bioassays ^*  (France)

Author keywords

Incidence progression; Knee; Osteoarthritis; Periostin; Prevalence

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ANTIBODY SPECIFICITY; ARTICLE; BODY MASS; BONE METABOLISM; BREAST CANCER; CHI SQUARE TEST; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERPARATHYROIDISM; INCIDENCE; INTERPHALANGEAL JOINT; KELLGREN & LAWRENCE GRADING SYSTEM; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OSTEOPHYTE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; SPINE RADIOGRAPHY; WOMEN'S HEALTH; AGED; BLOOD; HAND JOINT; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OSTEOARTHRITIS, SPINE; PATHOPHYSIOLOGY; STATISTICAL MODEL;

AGED; BODY MASS INDEX; CELL ADHESION MOLECULES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HAND JOINTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OSTEOARTHRITIS, SPINE; PREVALENCE;

EID: 84942550279     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.05.015     Document Type: Article

References (38)

1. Oliviero F., Ramonda R., Punzi L. New horizons in osteoarthritis. Swiss Med Wkly 2010, 140:w13098.
2. Kraus V.B., Feng S., Wang S., White S., Ainslie M., Brett A., et al. Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression. Arthritis Rheum 2009, 60:3711-3722.
3. Cox L.G., van Donkelaar C.C., van Rietbergen B., Emans P.J., Ito K. Alterations to the subchondral bone architecture during osteoarthritis: bone adaptation vs endochondral bone formation. Osteoarthritis Cartilage 2013, 21:331-338.
4. Westacott C.I., Webb G.R., Warnock M.G., Sims J.V., Elson C.J. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1997, 40:1282-1291.
5. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005, 13:979-987.
6. Beyer C., Schett G. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage. Best Pract Res Clin Rheumatol 2010, 24:489-496.
7. Blom A.B., van Lent P.L., van der Kraan P.M., van den Berg W.B. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. Curr Drug Targets 2010, 11:620-629.
8. Kawaguchi H. Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process. J Bone Min Res 2009, 24:8-11.
9. Lories R.J., Corr M., Lane N.E. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 2013, 9:328-339.
10. Chou C.H., Wu C.C., Song I.W., Chuang H.P., Lu L.S., Chang J.H., et al. Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther 2013, 15:R190.
11. Chou C.H., Lee C.H., Lu L.S., Song I.W., Chuang H.P., Kuo S.Y., et al. Direct assessment of articular cartilage and underlying subchondral bone reveals a progressive gene expression change in human osteoarthritic knees. Osteoarthritis Cartilage 2013, 21:450-461.
12. Zhang R., Fang H., Chen Y., Shen J., Lu H., Zeng C., et al. Gene expression analyses of subchondral bone in early experimental osteoarthritis by microarray. PLoS One 2012, 7:e32356.
13. Dwek J.R. The periosteum: what is it, where is it, and what mimics it in its absence?. Skelet Radiol 2010, 39:319-323.
14. Kashima T.G., Nishiyama T., Shimazu K., Shimazaki M., Kii I., Grigoriadis A.E., et al. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. Hum Pathol 2009, 40:226-237.
15. Loeser R.F., Olex A.L., McNulty M.A., Carlson C.S., Callahan M.F., Ferguson C.M., et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum 2012, 64:705-717.
16. Bonnet N., Conway S.J., Ferrari S.L. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc Natl Acad Sci USA 2012, 109:15048-15053.
17. Merle B., Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int 2012, 23:1199-1212.
18. Rousseau J., Garnero P. Biological markers in osteoarthritis. Bone 2012, 51:265-277.
19. Arlot M.E., Sornay-Rendu E., Garnero P., Vey-Marty B., Delmas P.D. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Min Res 1997, 12:683-690.
20. Peterfy C., Li J., Zaim S., Duryea J., Lynch J., Miaux Y., et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skelet Radiol 2003, 32:128-132.
21. Garnero P., Sornay-Rendu E., Arlot M., Christiansen C., Delmas P.D. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. Arthritis Rheum 2004, 50:3137-3144.
22. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
23. Gensburger D., Roux J.P., Arlot M., Sornay-Rendu E., Ravaud P., Chapurlat R. Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res 2010, 12:1699-1705.
24. Lane N.E., Nevitt M.C., Genant H.K., Hochberg M.C. Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar disc degeneration. J Rheumatol 1993, 20:1911-1918.
25. Sornay-Rendu E., Munoz F., Duboeuf F., Delmas P.D., Study O. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study. J Bone Min Res 2004, 19:1994-1999.
26. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990, 33:1601-1610.
27. Christgau S., Garnero P., Fledelius C., Moniz C., Ensig M., Gineyts E., et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001, 29:209-215.
28. Szulc P., Seeman E., Duboeuf F., Sornay-Rendu E., Delmas P.D. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Min Res 2006, 21:1856-1863.
29. Moody R.G., Williamson M.P. Structure and function of a bacterial Fasciclin I Domain Protein elucidates function of related cell adhesion proteins such as TGFBIp and periostin. FEBS Open Bio 2013, 3:71-77.
30. Ma B., van Blitterswijk C.A., Karperien M. A Wnt/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum 2012, 64:2589-2600.
31. Ma B., Landman E.B., Miclea R.L., Wit J.M., Robanus-Maandag E.C., Post J.N., et al. WNT signaling and cartilage: of mice and men. Calcif Tissue Int 2013, 92:399-411.
32. Bonnet N., Standley K.N., Bianchi E.N., Stadelmann V., Foti M., Conway S.J., et al. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 2009, 284:35939-35950.
33. Ma D., Zhang R., Sun Y., Rios H.F., Haruyama N., Han X., et al. A novel role of periostin in postnatal tooth formation and mineralization. J Biol Chem 2011, 286:4302-4309.
34. Rousseau J., Sornay-Rendu E., Bertholon C., Chapurlat R., Garnero P. Serum periostin is associated with fracture risk in postmenopausal women: a 7 years prospective analysis of the OFELY study. J Clin Endocrinol Metab 2014, 99:2533-2539.
35. Merle B., Bouet G., Rousseau J.C., Bertholon C., Garnero P. Periostin and transforming growth factor -induced protein (TGFIp) are both expressed by osteoblasts and osteoclasts. Cell Biol Int 2014, 38:398-404.
36. Liu G., Peacock M., Eilam O., Dorulla G., Braustein E., Johnston C.C. Effect of osteoarthritis in the lumbar spine and hip bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 1997, 7:564-569.
37. O'Neill T.W., McCloskey E.V., Kanis J.A., Bhalla A.K., Reeve J., Reid D.M., et al. The distribution, determinants and clinical correlates of vertebral osteophytosis: a population-based survey. J Rheumatol 1999, 26:842-848.
38. Nevitt M.C., Ettinger B., Black D.M., Stone K., Jamal S.A., Ensrud K., et al. The association of radiological detected vertebral fractures with back pain and function: a prospective study. Ann Intern. Med 1998, 128:793-800.